Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Valproate in Wolfram Syndrome
NCT03717909Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Dec 2018
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of valproic acid in Wolfram syndrome (2 arms), sponsored by University of Birmingham. Primary endpoint: Visual acuity at 36 months. Started Dec 2018; status: completed.
02
Drugs
valproic acid
03
Conditions
Wolfram syndrome
Beyond the preview
Go deeper on NCT03717909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717909.